Articles for AstraZeneca (LSE: AZN)

These two FTSE 100 dividends stars still look cheap

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued. More »

Do these 3 low yielders offer high growth prospects?

A sky-high yield isn't everything these days, is it? Harvey Jones investigates. More »

Is this a better healthcare buy than AstraZeneca plc after today’s update?

Will this healthcare stock keep beating AstraZeneca plc (LON: AZN)? More »

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN) in the pharma stakes? More »

These two large caps look seriously undervalued

These two large caps could be the most undervalued in the FTSE 100. More »

Should you pile into this healthcare stock after today’s update?

Is this healthcare stock a 'must-buy'? More »

Can you really trust these Footsie big yielders to pay out?

Royston Wild discusses the payout prospects of three FTSE 100 dividend stocks. More »

Is this the best healthcare stock money can buy after today’s update?

Should you buy this stock or a sector peer following today's news? More »

Is now the right time to buy these Neil Woodford dividend stocks?

In the light of recent gains, Roland Head takes a fresh look at three of fund manager Neil Woodford's biggest holdings. More »

Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?

Edward Sheldon looks at Hikma Pharmaceuticals plc's (LON: HIK) interim results statement and examines whether the long-term growth story is still intact. More »

What does AstraZeneca plc’s deal with Pfizer mean for shareholders?

Should you buy, sell or hold AstraZeneca plc (LON: AZN) after the company's Pfizer deal? More »

3 stocks to help you retire early

Retirement planning requires a long-term view and these three shares could bring retirement a big step closer. More »

Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?

After recent gains is it time to sell GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)? More »

These FTSE 100 stars have exploded in Q3! And they’re not finished yet

Royston Wild considers the share price potential of three FTSE 100 (INDEXFTSE: UKX) fireworks. More »

Why now is the perfect time to buy these 3 super income stocks

These three shares look set to deliver strong returns over the medium-to-long term and the interest rate cut could make them even more attractive. More »

Are these the FTSE 100’s ‘safest’ dividend stocks?

Royston Wild reveals four FTSE 100 (INDEXFTSE: UKX) giants with terrific payout prospects. More »

Tech vs biotech: Is AstraZeneca plc or Apple Inc. the better buy?

Should you invest in biotech giant AstraZeneca plc (LON:AZN) or consumer king Apple Inc. (NASDAQ:AAPL)? More »

Should you take a look at these 3 shares after today’s news?

Three great shares to keep an eye on for future investment potential. More »

3 post-Brexit picks I’d buy now

Barratt Developments plc (LON:BDEV), Aviva plc (LON:AV) and AstraZeneca plc (LON:AZN) are three candidates for your watch list. More »

Here’s what Neil Woodford has been buying and selling since the Brexit vote

How has the UK's most renowned investor reacted to the referendum result? Here's what Neil Woodford has been up to. More »

Your browser (Internet Explorer 8 or older) is out of date. It has known security flaws and may not display all features of this and other websites. We recommend updating to Google Chrome.